Sugi Predict

Sugi Predict / Compounds / SCHEMBL23271908

SCHEMBL23271908

SCHEMBL23271908

Cc1ccc2cc3ccccc3c(OC(=O)OC(C)C)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 3/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ KDM4E B2RXH2 5/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ MAPT P10636 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CYP1A2 P05177 5/20 0.36
▸ ELANE P08246 1/20 0.36
▸ KCNJ11 Q14654 1/20 0.35
▸ HPGD P15428 3/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ AKR1B1 P15121 1/20 0.35
▸ MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30003221 1.00 CYP2A6 (0.39) CYP2A6TDP1KDM4EALDH1A1MAPT
SCHEMBL23271668 0.90 KDM4E (0.42) TDP1KDM4EALDH1A1MAPTLMNA
SCHEMBL30002558 0.90 KDM4E (0.42) TDP1KDM4EALDH1A1MAPTLMNA
SCHEMBL23271827 0.87 HSD17B10 (0.42) CYP2A6TDP1KDM4EALDH1A1MAPT
SCHEMBL30003198 0.86 KDM4E (0.41) TDP1KDM4EALDH1A1MAPTPKM
SCHEMBL20398665 0.86 KDM4E (0.41) TDP1KDM4EALDH1A1MAPTPKM
SCHEMBL23271963 0.83 CYP1A2 (0.40) CYP2A6TDP1KDM4EALDH1A1MAPT
SCHEMBL30003464 0.83 CYP1A2 (0.40) CYP2A6TDP1KDM4EALDH1A1MAPT
SCHEMBL23271953 0.82 ALDH1A1 (0.43) TDP1KDM4EALDH1A1MAPTLMNA
SCHEMBL20398704 0.81 KDM4E (0.43) TDP1KDM4EALDH1A1MAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11613509-B2 Radical polymerization control agent and radical polymerization control method KAWASAKI KASEI CHEMICALS LTD. (JP) 2023-03-28 — — US disclosed
CN-110891980-B Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2022-09-30 — — CN disclosed
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-04-29 — — US disclosed
CN-110891980-A Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2020-03-17 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11613509-B2 Radical polymerization control agent and radical polymerization control method PPOX, NOX4, CROCC CYP2A6 1731/4885TDP1 4412/4885KDM4E 1028/4885
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD PPOX, NOX4, CROCC CYP2A6 1731/4885TDP1 4412/4885KDM4E 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.